Don't qualify for this program? Visit the DBAs to look for financial assistance based on your diagnosis.  
 

Novartis Patient Assistance Foundation, Inc. (NPAF)

This program provides medication at no cost.

Provided by: Novartis Pharmaceuticals Corporation

PO Box 52029
Phoenix, AZ 85072-2029

TEL: 800-277-2254


FAX: 855-817-2711 		Languages Spoken:

English, Others By Translation Service

Program Website

 

Program Applications and Forms

Novartis Patient Assistance Foundation, Inc. Enrollment Application: Contact program
 

Medications
  • artmether-lumefantrine tablet (Coartem) Tablet
 

Eligibility Requirements   
Insurance Status Contact program for details.
Those with Part D Eligible? Contact program for details.
Income Based on FPL
Diagnosis/Medical Criteria Not specified
US Residency Required? Must be residing in the US or US territory
   

Application
Obtaining Call or download
Receiving Faxed
Returning Fax or mail
Doctor's Action Complete section, sign, attach required documents
Applicant's Action Complete section, sign, attach required documents
Decision Communicated Patient and Doctor are notified
Decision Timeframe Not specified
   

Medication
Amount/Supply Varies
Sent To Patient's home, unless otherwise noted
Delivery Time Not specified
Refill Process Contact program for details.
Limit Not specified
Re-application New application, new documentation yearly
   

Additional Information
Novartis Oncology Products: To start the application process apply to PANO (Patient Assistance Now Oncology) at www.patient.novartisoncology.com or (800) 282-7630.

Kesimpta: To start the application process apply to Alongside™ Kesimpta at www.Kesimpta.com or (855) 537-4678.

Leqvio: To start the application process apply to Leqvio Service Center at www.Leqvio.com or (833) 537-8462.

Mayzent: To start the application process apply to Alongside™ Mayzent at www.Mayzent.com or (877) 629-9368.

All medication will be shipped directly to the patient, unless otherwise noted.

Please contact the program for a complete product listing. www.pap.novartis.com
Updated March 20, 2023